Suggestions
Deborah Hemingway, PhD
Investor | Entrepreneur | Research Scientist | Innovator | Board Director | Strategic Advisor | Startup Champion
Professional Background
Deborah Hemingway, PhD, is a highly accomplished and versatile professional with a robust background in biophysics, entrepreneurship, and advisory roles in various reputable organizations. She holds a Doctor of Philosophy (Ph.D.) in Biophysics from the prestigious University of Maryland, where her research and studies have contributed significantly to the scientific community. Her academic excellence is complemented by her diverse educational background that includes two undergraduate degrees: a Bachelor of Science (B.S.) and a Bachelor of Business Administration (B.B.A.) from Ohio University, along with a minor in French.
Her career trajectory is marked by impressive leadership roles in multiple companies. Deborah has been at the forefront of innovation and entrepreneurship, having founded and served as CEO for several companies, including Leon Scientific, The Meal Kit Company, and CellTrace. She is recognized for her ability to translate complex scientific principles into viable business products, making significant contributions to the sectors of biotechnology and consumer goods.
In addition to her entrepreneurial accomplishments, Deborah has played key advisory roles, enhancing the strategic direction of various organizations. Her experience includes serving as an Advisory Board Chair at NeuroSonics Medical, Inc., where she advised on integrating neuroscience and technology to improve healthcare outcomes. Furthermore, her positions at Aloe Therapeutics and Djit Medtech demonstrate her commitment to advancing healthcare solutions that harness cutting-edge technology.
Education and Achievements
Deborah Hemingway's educational background is impressive, beginning with her B.S. and B.B.A. from Ohio University. This comprehensive education provided her with a strong foundation in both the sciences and business, enabling her to approach problems with a well-rounded perspective.
She pursued her Ph.D. in Biophysics at the University of Maryland, where she engaged in extensive research that likely contributed to her understanding of the scientific aspects of entrepreneurship and innovation. Her academic journey has equipped her with the analytical skills necessary to drive projects forward and innovate within various fields.
Deborah’s myriad professional roles, from Managing Partner at Ecphora Capital to her advisory positions, underline her versatility and thought leadership. Her tenure as a Board Member at the Dingman Center for Entrepreneurship reflects her dedication to nurturing new businesses and guiding emerging entrepreneurs toward success.
Throughout her career, she has demonstrated her capacity to connect scientific research with commercial opportunities, fostering a spirit of innovation and collaboration. This unique blend of entrepreneurial spirit and scientific expertise places her in a distinguished position within the technology and health sectors.
Notable Achievements
Throughout her career, Deborah Hemingway, PhD, has achieved numerous accomplishments that underscore her leadership and expertise.
- Entrepreneurship & Leadership: As the Founder and CEO of Leon Scientific and The Meal Kit Company, Deborah has led teams in developing innovative products that merge science with market needs.
- Advisory Roles: Deborah's work with organizations like NeuroSonics Medical, Inc. and PediaMetrix emphasizes her commitment to enhancing healthcare technology and educational solutions through effective advisory strategies.
- Board Memberships: Holding influential board positions at various startups and organizations, including the Dingman Center for Entrepreneurship and Mi-Helper, Inc., she has actively contributed to shaping the future of entrepreneurial ventures and technology integration in healthcare.
- Mentorship: By serving on advisory boards and engaging with startups, Deborah has played a vital mentorship role, enabling emerging entrepreneurs to navigate challenges and leverage opportunities in rapidly evolving markets.
Deborah’s contributions across multiple sectors illustrate not only her intellectual prowess but also her steadfast commitment to fostering innovation, education, and the practical application of scientific research. She is a leading figure whose work continues to resonate within the realms of biophysics, entrepreneurship, and healthcare technology.
Highlights
I recently had the privilege of serving as a judge at the MedTech Innovator Pitch event in DC. I’d first like to give a shoutout to our inspirational, Maryland-based Hometown Heroes: Chibueze Ihenacho (CEO of ARMR Systems), Jason Winder (CEO of Sonogen Medical Inc.), Sue Fisher Carr (CEO of CarrTech Corporation), Mustafa Al-Adhami, Ph.D. (CEO of Astek Diagnostics), and Sasank Vemulapati (CEO of Lo Bio-whom I met for the first time!) Very proud to have each of these companies in our state!
As judges, we met with many CEOs, and our evaluation process was guided by a structured rubric to assess each company and steer our conversations. What was one of the first questions on the rubric? 'Rate the innovation of the technology.'
That is a great question to start with because isn’t this what it all comes down to? How innovative the technology is directly relates to the impact it can make.
We all have such limited time, energy, and resources. If we, as innovators, entrepreneurs, and visionaries, are going to devote our entirety to a cause, what does it mean in the end? What impact will it make? Entrepreneurs sacrifice so much for their startups, dedicating their lives, time, money, and energy (and I could go on) to bring new products to market. So, if there is going to be so much sacrifice, let it be for something big—something that will impact the world!
This is our philosophy at Ecphora Capital. If you are going in, go all in! Let’s come together to build transformational, revolutionary, innovative technology that influences human health not only in our state and nation but globally. Let’s impact the world!
#TransformationalInnovation #MedTech #Entrepreneurship #VC #EcphoraCapital #WomeninVC #VCsGiveBack #ImpactTheWorld
This year's RESI South 2024 Conference in Atlanta featured an impressive Seed-stage investor panel featuring institutional investors from across the nation. (And I was honored to be included!) One of my favorite questions for the panelists was about how to find investors. This question is top of mind for so many entrepreneurs–especially given the dry early-stage investing environment.
Among the advice given, Ron Levin from Alumni Ventures recommended using PitchBook to identify active investors, a strategy I strongly endorse for its effectiveness in pinpointing active investors in your space.
This, however, prompted concerns from the audience regarding access to PitchBook due to its high cost. Some suggested leveraging connections with organizations and/or higher education institutions to obtain PitchBook data, (though it's unclear if this approach aligns with PitchBook's policies or if it's widely feasible for most founders).
In response, I would like to share a teaser about a forthcoming resource from my firm, Ecphora Capital, designed to address this exact challenge for early-stage medtech investors……... Keep an eye out in the coming days for a resource that aims to aid our incredible medtech founders in navigating the investor landscape for who is investing now!
Can’t wait to release our beta version! Stay tuned!!! #CantWait #RESI #RESISOUTH #WomeninVC #VCsGiveBack #MedTech Life Science Nation (LSN)
